Clinical significance of normalized airflow obstruction in patients with chronic obstructive pulmonary disease.

[1]  M. Miravitlles,et al.  Unravelling young COPD and pre-COPD in the general population , 2022, ERJ Open Research.

[2]  Meilan K. Han,et al.  Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission , 2022, The Lancet.

[3]  C. Rhee,et al.  Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease , 2022, Respiratory Research.

[4]  E. Bleecker,et al.  Reversible Airflow Obstruction Predicts Future COPD Development in the SPIROMICS Cohort. , 2022, American journal of respiratory and critical care medicine.

[5]  Yimin Zhu,et al.  Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging , 2021, Frontiers in Medicine.

[6]  G. Davey Smith,et al.  Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. , 2021, The Lancet. Respiratory medicine.

[7]  Meilan K. Han,et al.  Treatment Trials in Pre-COPD and Young COPD: Time to Move Forward. , 2021, American journal of respiratory and critical care medicine.

[8]  E. Regan,et al.  Significant spirometric transitions and Preserved Ratio Impaired Spirometry (PRISm) among ever-smokers. , 2021, Chest.

[9]  J. Wedzicha,et al.  An Updated Definition and Severity Classification of COPD Exacerbations: The Rome Proposal. , 2021, American journal of respiratory and critical care medicine.

[10]  J. Vestbo,et al.  Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. , 2021, American journal of respiratory and critical care medicine.

[11]  J. Wedzicha,et al.  From GOLD 0 to Pre-COPD , 2020, American journal of respiratory and critical care medicine.

[12]  D. Kim,et al.  Clinical Characteristics and Changes of Clinical Features in Patients with Asthma-COPD Overlap in Korea according to Different Diagnostic Criteria , 2020, Tuberculosis and respiratory diseases.

[13]  A. Comellas,et al.  Preserved Ratio Impaired Spirometry in a Spirometry Database , 2020, Respiratory Care.

[14]  J. Vestbo,et al.  Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits , 2020, Thorax.

[15]  G. Brusselle,et al.  Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study , 2019, European Respiratory Journal.

[16]  A. Agustí,et al.  Lung function trajectories in health and disease. , 2019, The Lancet. Respiratory medicine.

[17]  E. Regan,et al.  Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study , 2018, American journal of respiratory and critical care medicine.

[18]  S. H. Lee,et al.  Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea , 2018, Tuberculosis and respiratory diseases.

[19]  A. Agustí,et al.  COPD beyond smoking: new paradigm, novel opportunities. , 2018, The Lancet. Respiratory medicine.

[20]  P. Su,et al.  Comparison of different staging methods for COPD in predicting outcomes , 2018, European Respiratory Journal.

[21]  B. Celli,et al.  COPD: time to improve its taxonomy? , 2018, ERJ Open Research.

[22]  D. Sin,et al.  Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets , 2017, British Medical Journal.

[23]  Jeffrey L. Curtis,et al.  Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease , 2016, American journal of respiratory and critical care medicine.

[24]  Dirkje S Postma,et al.  The Asthma-COPD Overlap Syndrome. , 2015, The New England journal of medicine.

[25]  J. Soriano,et al.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.

[26]  J. Bourbeau,et al.  Clinical Relevance of Diagnosing COPD by Fixed Ratio or Lower Limit of Normal: A Systematic Review , 2014, COPD.

[27]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[28]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[29]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.